One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer-Reference-Cited by-同舟云学术

One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer

Published:2013-09 Issue:14 Volume:49 Page:2986-2994
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ejlertsen Bent,Jensen Maj-Britt,Elversang Johanna,Rasmussen Birgitte B.,Andersson Michael,Andersen Jørn,Nielsen Dorte L.,Cold Søren,Mouridsen Henning T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study;Rivkin;J Clin Oncol,1994

2. Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.

3. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII;Crivellari;J Clin Oncol,2000

4. Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

5. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long term outcome among 100 000 women in 123 randomised trials, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Peto;Lancet,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials;Cancers;2024-04-29

2. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial;Radiotherapy and Oncology;2022-05

3. Luminal A Breast Cancer and Molecular Assays: A Review;The Oncologist;2018-02-22

4. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration;Acta Oncologica;2017-12-05

5. Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial;Journal of Clinical Oncology;2017-08-10